"Hospital Duran i Reynals es un complejo que alberga Hestia Duran i Reynals y el ICO. Hestia Duran i Reynals es un centro gestionado por Hestia Alliance que ofrece una prestación integral de servicios sanitarios y sociales gracias a unas completas instalaciones con 428 camas y profesionales orientados a garantizar el máximo bienestar clínico, psicológico y social al paciente mediante una atención individualizada y teniendo en cuenta su grado de dependencia. Presta servicios de atención sociosanitaria (larga estancia, convalecencia y cuidados paliativos) y de salud mental, en régimen de hospitalización u Hospital de Día. Por su parte, el ICO, dependiente del CatSalut, trabaja para reducir el impacto del cáncer en Cataluña."

During the past decade, Hospital Duran i Reynals; Servicio de Hematologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Duran i Reynals; Servicio de Hematologia" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Duran i Reynals; Servicio de Hematologia" are "Non-Hodgkin's Lymphoma" (2 trials), "B-cell Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "High-Grade B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Duran i Reynals; Servicio de Hematologia" in a lesser frequency.

Most popular intervention types in "Hospital Duran i Reynals; Servicio de Hematologia" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (5 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials) and "Vincristine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Duran i Reynals; Servicio de Hematologia" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Duran i Reynals; Servicio de Hematologia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Duran i Reynals; Servicio de Hematologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Duran i Reynals; Servicio de Hematologia, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".